Showing results (3011-3020 of 3,353) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|April 12, 2006
Economic and developmental considerations for pharmacogenomic technologyJohn A Vernon, Scott J Johnson, W Keener Hughen, et al.
Pharmacoeconomics|April 12, 2006
Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessmentZoë Philips, Laura Bojke, Mark Sculpher, et al.
Pharmacoeconomics|April 12, 2006
A cost-utility analysis of losartan versus atenolol in the treatment of hypertension with left ventricular hypertrophyAslam H Anis, Huiying Sun, Sonia Singh, et al.
Pharmacoeconomics|April 6, 2004
Longitudinal versus cross-sectional methodology for estimating the economic burden of breast cancer: a pilot studyC Daniel Mullins, Junling Wang, Jesse L Cooke, et al.
Pharmacoeconomics|April 6, 2004
Pharmacoeconomic analysis of amphotericin B lipid complex versus liposomal amphotericin B in the treatment of fungal infectionsJoseph L Kuti, Srividya Kotapati, Peter Williams, et al.
Pharmacoeconomics|April 6, 2004
Cost effectiveness of combination therapy with pioglitazone for type 2 diabetes mellitus from a german statutory healthcare perspectiveKurt Neeser, Georg Lübben, Uwe Siebert, et al.
Pharmacoeconomics|February 21, 2004
Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis CSean D Sullivan, Antonio Craxi, Alfredo Alberti, et al.
Pharmacoeconomics|September 29, 2004
Cost effectiveness of ACE inhibitor treatment for patients with type 1 diabetes mellitusFrederick B Dong, Stephen W Sorensen, Diane L Manninen, et al.
Pharmacoeconomics|July 1, 2005
The state of patient-reported outcomes in atrial fibrillation : a review of current measuresKarin Coyne, Mary Kay Margolis, Susan Grandy, et al.
Pharmacoeconomics|July 1, 2005
Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthmaBernd Brüggenjürgen, Dagmar Selim, Peter Kardos, et al.
Pageof 336